In the News

Digital Health Assessments May Improve Parkinson Disease Diagnosis

Results from the 12-month, multicenter, observational study, WATCH-PD, were recently published in the journal Nature. The researchers found significant associations between digital biomarkers with a wearable device and conventional clinical scoring methods used in Parkinson’s disease (PD). Working with Clinical Ink to gather the real-world...

Private AI and Replica Analytics announce partnership to tackle data privacy

Replica Analytics, an Aetion company, is partnering with data privacy software solutions developer Private AI. The partnership is a response to an urgent need for a privacy-preserving solution in healthcare and aims to provide a comprehensive solution for healthcare’s data privacy and security challenges. Replica Analytics’...

Aster Insights Names Dr. Anand Shah as Chief Executive Officer

Aster Insights has announced the appointment of Dr. Anand Shah as chief executive officer, effective immediately. He succeeds Jim Gabriele, who has stepped down from his position. Gabriele and Shah have collaborated closely on a number of strategic, operational, and business development initiatives over the...

Clinical ink Announces New Continuous Glucose Monitoring Solution

Clinical Ink, a global life science technology company, now offers continuous glucose monitoring (CGM) within its integrated digital biomarker solution. The new modules enable remote collection, central storage, and analysis of sensor data from commercially available devices for use in diabetes clinical trials. The solution...

RCT-DUPLICATE Findings Demonstrate Capability of Real-World Evidence Studies to Reach Conclusions Similar to Randomized Clinical Trials

Real-world evidence (RWE) technology and analytics company Aetion has announced the culmination of the RCT-DUPLICATE demonstration project, with complete findings published in The Journal of the American Medical Association (JAMA). This three-year initiative tested whether researchers asking clinical questions in real-world data (RWD)—data from patients’...

Inside the new world of healthcare data

In a recent episode of the PharmaPhorum podcast, Evidation co-CEO and Executive Chair of the Board Deborah Kilpatrick discussed healthcare data collection in 2023 and how it intersects with stakeholders across the ecosystem, from tech and pharma companies to research participants. The discussion began with data...